Dustin A. Deming

Also affiliated with University of Wisconsin Carbone Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 30 papers. Top paper: “Autofluorescence Imaging of Treatment Response in Neuroendocrine Tumor Organoids”.

Autofluorescence Imaging of Treatment Response in Neuroendocrine Tumor Organoids

Cancers(2021)10.3390/cancers13081873

N/A

0.596DataRank · unranked

52 citations

Christopher P. Babiarz, Ava R. VanDommelen, Cheri A. Pasch, Linda Clipson, Kristina A. Matkowskyj +3 more

Integrating Subclonal Response Heterogeneity to Define Cancer Organoid Therapeutic Sensitivity

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.15.464556

N/A

0.345DataRank · unranked

9 citations

Shujah Rehman, Katherine A. Johnson, Amani A. Gillette, Aishwarya Sunil, Peter F. Favreau +29 more

NRG-GI008: Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.tps212

N/A

0.312DataRank · unranked

7 citations

Yan Lin, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, İbrahim Halil Şahin +8 more

Phase II study of copanlisib in patients with tumors with PIK3CA mutations (PTEN loss allowed): NCI MATCH EAY131-Z1F.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3506

N/A

0.269DataRank · unranked

5 citations

Fengmin Zhao, Dustin A. Deming, Edith P. Mitchell, John Joseph Wright, L. Austin Doyle +15 more

Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US): NRG-GI008.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps3643

N/A

0.208DataRank · unranked

3 citations

Yan Lin, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, İbrahim Halil Şahin +9 more

Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US): NRG-GI008.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps3634

N/A

0.104DataRank · unranked

1 citations

Yu Guan, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, Ibrahim Halil Sahin +10 more

Volumetric growth tracking of patient-derived cancer organoids using optical coherence tomography

Biomedical Optics Express(2021)10.1364/boe.428197

N/A

0DataRank · unranked

31 citations

Dustin A. Deming, Melissa C. Skala, Daniel A. Gil

Patient-derived cancer organoid tracking with wide-field one-photon redox imaging to assess treatment response

Journal of Biomedical Optics(2021)10.1117/1.jbo.26.3.036005

N/A

0DataRank · unranked

26 citations

Dustin A. Deming, Melissa C. Skala, Daniel A. Gil

Multi‐ancestral origin of intestinal tumors: Impact on growth, progression, and drug efficacy

Cancer Reports(2021)10.1002/cnr2.1459

N/A

0DataRank · unranked

4 citations

Brock J. Gilsdorf, Amanda M. Wisinger, Elise R. Warda, Shanna Wiegand, Christopher D. Zahm +12 more

Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer:NRG-GI005 (COBRA).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.tps148

N/A

0DataRank · unranked

5 citations

Greg Yothers, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, Atif Iqbal +7 more

Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.11.10.467836

N/A

0DataRank · unranked

2 citations

Gauri Deb, Adam Officer, Alexander Cicala, Chelsea Hope, Philip B. Emmerich +11 more

Phase II/III study of Circulating tumOr DNA as a predictive BiomaRker in Adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps3622

N/A

0DataRank · unranked

2 citations

Greg Yothers, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, Atif Iqbal +7 more

Impact of baseline culture conditions of mouse-derived cancer organoids when determining therapeutic response and tumor heterogeneity

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.12.464087

N/A

0DataRank · unranked

1 citations

Autumn M. Olson, Alyssa K. DeZeeuw, Amani A. Gillette, Gioia C. Sha, Katherine A. Johnson +6 more

Sensitivity of HER2-amplified colorectal organotypic cancer spheroids at ex vivo resistance to panitumumab and trastuzumab.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.68

N/A

0DataRank · unranked

0 citations

Lucas C. Zarling, Aishwarya Sunil, Shujah Rehman, Katherine A. Johnson, Sarbjeet Makkar +8 more

Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment

Cell Reports(2022)10.1016/j.celrep.2022.111201

N/A

0DataRank · unranked

34 citations

Gauri Deb, Alexander Cicala, Adam Officer, Chelsea Hope, Adam Pagenkopf +15 more

Impact of baseline culture conditions of cancer organoids when determining therapeutic response and tumor heterogeneity

Scientific Reports(2022)10.1038/s41598-022-08937-z

N/A

0DataRank · unranked

20 citations

Jeremy D. Kratz, Autumn M. Olson, Aishwarya Sunil, Alyssa K. DeZeeuw, Amani A. Gillette +7 more

Inhibition of B-cell lymphoma 2 family proteins alters optical redox ratio, mitochondrial polarization, and cell energetics independent of cell state

Journal of Biomedical Optics(2022)10.1117/1.jbo.27.5.056505

N/A

0DataRank · unranked

5 citations

Rebecca A. DeStefanis, Stephanie Pritzl, Dustin A. Deming, Melissa C. Skala, Amani A. Gillette

Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.tps233

N/A

0DataRank · unranked

3 citations

Greg Yothers, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, Atif Iqbal +8 more

Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps259

N/A

0DataRank · unranked

1 citations

Greg Yothers, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, Atif Iqbal +8 more

NRG GI008: Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-US).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps260

N/A

0DataRank · unranked

0 citations

Yan Lin, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, İbrahim Halil Şahin +10 more

Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps3625

N/A

0DataRank · unranked

0 citations

Greg Yothers, Scott Kopetz, Shannon L. Puhalla, Peter C. Lucas, Atif Iqbal +8 more

The dichotomous roles of microbial-modified bile acids 7-oxo-DCA and isoDCA in intestinal tumorigenesis

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2317596121

N/A

0DataRank · unranked

19 citations

Fei Sun, Henry Secaira-Morocho, Alisa Hui, Ke Wang, Chunmiao Cai +13 more

Efficacy and Safety of Olomorasib in Combination With Pembrolizumab in Treatment of Patients With KRAS G12C-Mutant Advanced NSCLC

Journal of Thoracic Oncology(2025)10.1016/j.jtho.2025.11.018

N/A

0DataRank · unranked

5 citations

Natraj Reddy Ammakkanavar, Antoine Hollebecque, Dae Ho Lee, Takafumi Koyama, Philippe A. Cassier +20 more

Metabolic Heterogeneity in Patient Tumor-Derived Organoids by Primary Site and Drug Treatment

Frontiers in Oncology(2020)10.3389/fonc.2020.00553

N/A

0DataRank · unranked

142 citations

Christine M. Walsh, Carley M. Sprackling, Cheri A. Pasch, Dan L. Pham, Karla Esbona +12 more

Micro-environmental changes indicate potential for subclinical intestinal tissue damage in early-age-onset colorectal cancer patients

Gastroenterology report(2025)10.1093/gastro/goaf015

N/A

0DataRank · unranked

2 citations

Katherine A. Johnson, Philip B Emmerich, Linda Clipson, Cheri A. Pasch, Wei Zhang +3 more

Label-free redox imaging of patient-derived organoids using selective plane illumination microscopy

Biomedical Optics Express(2020)10.1364/boe.389164

N/A

0DataRank · unranked

33 citations

Jiaye He, Daniel A. Gil, Dustin A. Deming, Jan Huisken, Melissa C. Skala +1 more

NRG-GI005 (COBRA): Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.tps261

N/A

0DataRank · unranked

17 citations

Greg Yothers, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, Atif Iqbal +7 more

Phase II/III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps4121

N/A

0DataRank · unranked

4 citations

Greg Yothers, Scott Kopetz, Samuel A. Jacobs, Peter C. Lucas, Atif Iqbal +7 more

Predicting CD8+ T-cell infiltration in colorectal cancer using versican proteolysis across molecular profiles.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.189

N/A

0DataRank · unranked

2 citations

Philip B. Emmerich, Kristina A. Matkowskyj, Dustin A. Deming, Katherine A. Johnson

Defining population response of patient-derived colorectal cancer organoids against prospective clinical outcomes.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.177

N/A

0DataRank · unranked

0 citations

Amani A. Gillette, Shujah Rehman, Aishwarya Sunil, Katherine A. Johnson, Cheri A. Pasch +15 more